Skip to main content
Top
Published in: Infection 4/2019

01-08-2019 | Septicemia | Original Paper

Management of early- and late-onset sepsis: results from a survey in 80 German NICUs

Authors: Jana E. Litz, Sybelle Goedicke-Fritz, Christoph Härtel, Michael Zemlin, Arne Simon

Published in: Infection | Issue 4/2019

Login to get access

Abstract

Purpose

The management of early- (EOS) and late-onset sepsis (LOS) and neonatal intensive care units (NICUs) has not been extensively evaluated.

Methods

231 highly specialized level 1 and level 2 NICUs in Germany were asked to participate in an internet-based survey.

Results

The final analysis of anonymized datasets from 80 NICUs (response rate 34.6 %) compared university hospitals and regional neonatal referral centers. The survey describes potential areas of improvement concerning empirical treatment of infants with LOS with vancomycin and 3rd generation cephalosporins, minimal volume of blood sampling for aerobic culture, consideration of lumbar tap in any child with blood culture positive LOS and drug monitoring details for gentamicin and vancomycin.

Conclusion

In summary, this survey reveals a significant gap between recent national German guidelines and daily practices in German NICUs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Troger B, Gopel W, Faust K, et al. Risk for late-onset blood-culture proven sepsis in very-low-birth weight infants born small for gestational age: a large multicenter study from the German Neonatal Network. Pediatr Infect Dis J. 2014;33:238–43.CrossRefPubMed Troger B, Gopel W, Faust K, et al. Risk for late-onset blood-culture proven sepsis in very-low-birth weight infants born small for gestational age: a large multicenter study from the German Neonatal Network. Pediatr Infect Dis J. 2014;33:238–43.CrossRefPubMed
2.
go back to reference Stichtenoth G, Demmert M, Bohnhorst B, et al. Major contributors to hospital mortality in very-low-birth-weight infants: data of the birth year 2010 cohort of the German Neonatal Network. Klin Padiatr. 2012;224:276–81.CrossRefPubMed Stichtenoth G, Demmert M, Bohnhorst B, et al. Major contributors to hospital mortality in very-low-birth-weight infants: data of the birth year 2010 cohort of the German Neonatal Network. Klin Padiatr. 2012;224:276–81.CrossRefPubMed
3.
go back to reference Alshaikh B, Yusuf K, Sauve R. Neurodevelopmental outcomes of very low birth weight infants with neonatal sepsis: systematic review and meta-analysis. J Perinatol. 2013;33:558–64.CrossRefPubMed Alshaikh B, Yusuf K, Sauve R. Neurodevelopmental outcomes of very low birth weight infants with neonatal sepsis: systematic review and meta-analysis. J Perinatol. 2013;33:558–64.CrossRefPubMed
4.
go back to reference Reichert F, Piening B, Geffers C, Gastmeier P, Buhrer C, Schwab F. Pathogen-specific clustering of nosocomial blood stream infections in very preterm infants. Pediatrics. 2016;137:e 20152860.CrossRef Reichert F, Piening B, Geffers C, Gastmeier P, Buhrer C, Schwab F. Pathogen-specific clustering of nosocomial blood stream infections in very preterm infants. Pediatrics. 2016;137:e 20152860.CrossRef
5.
go back to reference Leistner R, Piening B, Gastmeier P, Geffers C, Schwab F. Nosocomial infections in very low birthweight infants in Germany: current data from the national surveillance system NEO-KISS. Klin Padiatr. 2013;225:75–80.CrossRefPubMed Leistner R, Piening B, Gastmeier P, Geffers C, Schwab F. Nosocomial infections in very low birthweight infants in Germany: current data from the national surveillance system NEO-KISS. Klin Padiatr. 2013;225:75–80.CrossRefPubMed
6.
go back to reference Cantey JB, Ronchi A, Sanchez PJ. Spreading the benefits of infection prevention in the neonatal intensive care unit. JAMA Pediatr. 2015;169:1089–91.CrossRefPubMed Cantey JB, Ronchi A, Sanchez PJ. Spreading the benefits of infection prevention in the neonatal intensive care unit. JAMA Pediatr. 2015;169:1089–91.CrossRefPubMed
7.
go back to reference Kermorvant-Duchemin E, Laborie S, Rabilloud M, Lapillonne A, Claris O. Outcome and prognostic factors in neonates with septic shock. Pediatr Crit Care Med. 2008;9:186–91.CrossRefPubMed Kermorvant-Duchemin E, Laborie S, Rabilloud M, Lapillonne A, Claris O. Outcome and prognostic factors in neonates with septic shock. Pediatr Crit Care Med. 2008;9:186–91.CrossRefPubMed
8.
go back to reference Patel SJ, Green N, Clock SA, et al. Gram-Negative Bacilli in infants hospitalized in the neonatal intensive care unit. J Pediatric Infect Dis Soc. 2017;6:227–30.PubMed Patel SJ, Green N, Clock SA, et al. Gram-Negative Bacilli in infants hospitalized in the neonatal intensive care unit. J Pediatric Infect Dis Soc. 2017;6:227–30.PubMed
9.
go back to reference Cantey JB. Optimizing the use of antibacterial agents in the neonatal period. Paediatr Drugs. 2016;18:109–22.CrossRefPubMed Cantey JB. Optimizing the use of antibacterial agents in the neonatal period. Paediatr Drugs. 2016;18:109–22.CrossRefPubMed
10.
go back to reference Cantey JB, Milstone AM. Bloodstream infections: epidemiology and resistance. Clin Perinatol. 2015;42:1–16 (vii).CrossRefPubMed Cantey JB, Milstone AM. Bloodstream infections: epidemiology and resistance. Clin Perinatol. 2015;42:1–16 (vii).CrossRefPubMed
11.
go back to reference Cantey JB, Patel SJ. Antimicrobial stewardship in the NICU. Infect Dis Clin North Am. 2014;28:247–61.CrossRefPubMed Cantey JB, Patel SJ. Antimicrobial stewardship in the NICU. Infect Dis Clin North Am. 2014;28:247–61.CrossRefPubMed
12.
go back to reference Cantey JB, Wozniak PS, Pruszynski JE, Sanchez PJ. Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study. Lancet Infect Dis. 2016;16:1178–84.CrossRefPubMed Cantey JB, Wozniak PS, Pruszynski JE, Sanchez PJ. Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study. Lancet Infect Dis. 2016;16:1178–84.CrossRefPubMed
13.
go back to reference Cantey JB, Wozniak PS, Sanchez PJ. Prospective surveillance of antibiotic use in the neonatal intensive care unit: results from the SCOUT study. Pediatr Infect Dis J. 2015;34:267–72.CrossRefPubMed Cantey JB, Wozniak PS, Sanchez PJ. Prospective surveillance of antibiotic use in the neonatal intensive care unit: results from the SCOUT study. Pediatr Infect Dis J. 2015;34:267–72.CrossRefPubMed
14.
go back to reference Lutsar I, Chazallon C, Carducci FI, et al. Current management of late onset neonatal bacterial sepsis in five European countries. Eur J Pediatr. 2014;173:997–1004.PubMed Lutsar I, Chazallon C, Carducci FI, et al. Current management of late onset neonatal bacterial sepsis in five European countries. Eur J Pediatr. 2014;173:997–1004.PubMed
15.
go back to reference Fernando AM, Heath PT, Menson EN. Antimicrobial policies in the neonatal units of the United Kingdom and Republic of Ireland. J Antimicrob Chemother. 2008;61:743–5.CrossRefPubMed Fernando AM, Heath PT, Menson EN. Antimicrobial policies in the neonatal units of the United Kingdom and Republic of Ireland. J Antimicrob Chemother. 2008;61:743–5.CrossRefPubMed
16.
go back to reference Liem TB, Krediet TG, Fleer A, Egberts TC, Rademaker CM. Variation in antibiotic use in neonatal intensive care units in the Netherlands. J Antimicrob Chemother. 2010;65:1270–5.CrossRefPubMed Liem TB, Krediet TG, Fleer A, Egberts TC, Rademaker CM. Variation in antibiotic use in neonatal intensive care units in the Netherlands. J Antimicrob Chemother. 2010;65:1270–5.CrossRefPubMed
17.
go back to reference Kadambari S, Heath PT, Sharland M, Lewis S, Nichols A, Turner MA. Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units. J Antimicrob Chemother. 2011;66:2647–50.CrossRefPubMed Kadambari S, Heath PT, Sharland M, Lewis S, Nichols A, Turner MA. Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units. J Antimicrob Chemother. 2011;66:2647–50.CrossRefPubMed
18.
go back to reference Leroux S, Zhao W, Betremieux P, Pladys P, Saliba E, Jacqz-Aigrain E. Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey. Arch Dis Child. 2015;100:394–8.CrossRefPubMed Leroux S, Zhao W, Betremieux P, Pladys P, Saliba E, Jacqz-Aigrain E. Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey. Arch Dis Child. 2015;100:394–8.CrossRefPubMed
19.
go back to reference Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut B; Ergänzende E. zur “Prävention nosokomialer Infektionen bei neonatologischen Intensivpflegepatienten mit einem Geburtsgewicht unter 1.500 g” (2007). Epidemiol Bulletin des Robert Koch-Instituts, Berlin. 2012;(16. January 2012/Nr. 2):13–15. Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut B; Ergänzende E. zur “Prävention nosokomialer Infektionen bei neonatologischen Intensivpflegepatienten mit einem Geburtsgewicht unter 1.500 g” (2007). Epidemiol Bulletin des Robert Koch-Instituts, Berlin. 2012;(16. January 2012/Nr. 2):13–15.
20.
go back to reference Christoph J, Dame C, Eckmanns T, et al. Risikocharakterisierung intensivmedizinisch behandelter Früh- und Neugeborener und Daten zur Ist-Situation in deutschen neonatologischen Intensivpflegestationen 2013 - Fachliche Erläuterungen zu folgender Empfehlung: Praktische Umsetzung sowie krankenhaushygienische und infektionspräventive Konsequenzen des mikrobiellen Kolonisationsscreenings bei intensivmedizinisch behandelten Früh- und Neugeborenen Ergänzende Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut, Berlin zur Implementierung der Empfehlungen zur Prävention nosokomialer Infektionen bei neonatologischen Intensivpflegepatienten mit einem Geburtsgewicht unter 1.500 g aus dem Jahr 2007 und 2012 (Epidemiologisches Bulletin 42/2013). Epidemiol Bulletin des Robert Koch-Instituts, Berlin 2013;Supplement zu Ausgabe 42(21. Oktober 2013). Christoph J, Dame C, Eckmanns T, et al. Risikocharakterisierung intensivmedizinisch behandelter Früh- und Neugeborener und Daten zur Ist-Situation in deutschen neonatologischen Intensivpflegestationen 2013 - Fachliche Erläuterungen zu folgender Empfehlung: Praktische Umsetzung sowie krankenhaushygienische und infektionspräventive Konsequenzen des mikrobiellen Kolonisationsscreenings bei intensivmedizinisch behandelten Früh- und Neugeborenen Ergänzende Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut, Berlin zur Implementierung der Empfehlungen zur Prävention nosokomialer Infektionen bei neonatologischen Intensivpflegepatienten mit einem Geburtsgewicht unter 1.500 g aus dem Jahr 2007 und 2012 (Epidemiologisches Bulletin 42/2013). Epidemiol Bulletin des Robert Koch-Instituts, Berlin 2013;Supplement zu Ausgabe 42(21. Oktober 2013).
21.
go back to reference Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut B. Praktische Umsetzung sowie krankenhaushygienische und infektionspräventive Konsequenzen des mikrobiellen Kolonisationsscreenings bei intensivmedizinisch behandelten Früh- und Neugeborenen -Ergänzende Empfehlung der KRINKO beim Robert Koch-Institut, Berlin, zur Implementierung der Empfehlungen zur Prävention nosokomialer Infektionen bei neonatologischen Intensivpflegepatienten mit einem Geburtsgewicht unter 1.500 g aus dem Jahr 2007 und 2012. Epidemiol Bulletin des Robert Koch-Instituts, Berlin. 2013;Nr. 42(21. Oktober 2013):421–433. Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut B. Praktische Umsetzung sowie krankenhaushygienische und infektionspräventive Konsequenzen des mikrobiellen Kolonisationsscreenings bei intensivmedizinisch behandelten Früh- und Neugeborenen -Ergänzende Empfehlung der KRINKO beim Robert Koch-Institut, Berlin, zur Implementierung der Empfehlungen zur Prävention nosokomialer Infektionen bei neonatologischen Intensivpflegepatienten mit einem Geburtsgewicht unter 1.500 g aus dem Jahr 2007 und 2012. Epidemiol Bulletin des Robert Koch-Instituts, Berlin. 2013;Nr. 42(21. Oktober 2013):421–433.
22.
go back to reference Smith A, Saiman L, Zhou J, Della-Latta P, Jia H, Graham PL. Concordance of gastrointestinal tract colonization and subsequent bloodstream infections with Gram-negative Bacilli in very low birth weight infants in the neonatal intensive care unit. Pediatr Infect Dis J. 2010;29:831–5.CrossRefPubMedPubMedCentral Smith A, Saiman L, Zhou J, Della-Latta P, Jia H, Graham PL. Concordance of gastrointestinal tract colonization and subsequent bloodstream infections with Gram-negative Bacilli in very low birth weight infants in the neonatal intensive care unit. Pediatr Infect Dis J. 2010;29:831–5.CrossRefPubMedPubMedCentral
23.
go back to reference Haertel C, Simon A, Geffers C, et al. Nosokomiale Infektionen bei Frühgeborenen—Umsetzung der KRINKO-Empfehlungen im Deutschen Frühgeborenennetzwerk. Monatsschr Kinderheilkd. 2013;161:27–33.CrossRef Haertel C, Simon A, Geffers C, et al. Nosokomiale Infektionen bei Frühgeborenen—Umsetzung der KRINKO-Empfehlungen im Deutschen Frühgeborenennetzwerk. Monatsschr Kinderheilkd. 2013;161:27–33.CrossRef
24.
go back to reference Deutsche Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin. Deutsche Gesellschaft für Pädiatrische Infektiologie, Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Arbeitsgemeinschaft der wissenschaftlichen Fachgesellschaften (AWMF). Bakterielle Infektionen bei Neugeborenen. AWMF Register No 024—008 2018; 30.04.2018. Deutsche Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin. Deutsche Gesellschaft für Pädiatrische Infektiologie, Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Arbeitsgemeinschaft der wissenschaftlichen Fachgesellschaften (AWMF). Bakterielle Infektionen bei Neugeborenen. AWMF Register No 024—008 2018; 30.04.2018.
25.
go back to reference Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut. Definition der Multiresistenz gegenüber Antibiotika bei gramnegativen Stäbchen im Hinblick auf Maßnahmen zur Vermeidung der Weiterverbreitung. Epidemiol Bull des Robert Koch-Instituts Berlin. 2011;12:337–9. Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut. Definition der Multiresistenz gegenüber Antibiotika bei gramnegativen Stäbchen im Hinblick auf Maßnahmen zur Vermeidung der Weiterverbreitung. Epidemiol Bull des Robert Koch-Instituts Berlin. 2011;12:337–9.
26.
go back to reference Cunningham CT, Quan H, Hemmelgarn B, et al. Exploring physician specialist response rates to web-based surveys. BMC Med Res Methodol 2015;1532. Cunningham CT, Quan H, Hemmelgarn B, et al. Exploring physician specialist response rates to web-based surveys. BMC Med Res Methodol 2015;1532.
27.
go back to reference Gemeinsamer Bundesausschuss (GbA). Beschluss des Gemeinsamen Bundesausschusses über eine Änderung der Qualitätssicherungs-Richtlinie Früh- und Reifgeborene/QFR-RL: (§ 7 Nachweisverfahren und Anlage 2 Anforderung zum Pflegepersonal) 2016;15. Dezember 2016. http://www.english.g-ba.de/. Gemeinsamer Bundesausschuss (GbA). Beschluss des Gemeinsamen Bundesausschusses über eine Änderung der Qualitätssicherungs-Richtlinie Früh- und Reifgeborene/QFR-RL: (§ 7 Nachweisverfahren und Anlage 2 Anforderung zum Pflegepersonal) 2016;15. Dezember 2016. http://​www.​english.​g-ba.​de/​.
28.
go back to reference Polin RA. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129:1006–15.CrossRefPubMed Polin RA. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129:1006–15.CrossRefPubMed
29.
go back to reference Mukherjee A, Davidson L, Anguvaa L, Duffy DA, Kennea N. NICE neonatal early onset sepsis guidance: greater consistency, but more investigations, and greater length of stay. Arch Dis Child Fetal Neonatal Ed. 2015;100:F248–9.CrossRefPubMed Mukherjee A, Davidson L, Anguvaa L, Duffy DA, Kennea N. NICE neonatal early onset sepsis guidance: greater consistency, but more investigations, and greater length of stay. Arch Dis Child Fetal Neonatal Ed. 2015;100:F248–9.CrossRefPubMed
30.
go back to reference Mukherjee A, Ramalingaiah B, Kennea N, Duffy DA. Management of neonatal early onset sepsis (CG149): compliance of neonatal units in the UK with NICE recommendations. Arch Dis Child Fetal Neonatal Ed. 2015;100:F185.CrossRefPubMed Mukherjee A, Ramalingaiah B, Kennea N, Duffy DA. Management of neonatal early onset sepsis (CG149): compliance of neonatal units in the UK with NICE recommendations. Arch Dis Child Fetal Neonatal Ed. 2015;100:F185.CrossRefPubMed
31.
go back to reference Denkel LA, Schwab F, Kola A, et al. The mother as most important risk factor for colonization of very low birth weight (VLBW) infants with extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E). J Antimicrob Chemother. 2014;69:2230–7.CrossRefPubMed Denkel LA, Schwab F, Kola A, et al. The mother as most important risk factor for colonization of very low birth weight (VLBW) infants with extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E). J Antimicrob Chemother. 2014;69:2230–7.CrossRefPubMed
32.
go back to reference Patel SJ, Oshodi A, Prasad P, et al. Antibiotic use in neonatal intensive care units and adherence with centers for disease control and prevention 12 step campaign to prevent antimicrobial resistance. Pediatr Infect Dis J. 2009;28:1047–51.CrossRefPubMedPubMedCentral Patel SJ, Oshodi A, Prasad P, et al. Antibiotic use in neonatal intensive care units and adherence with centers for disease control and prevention 12 step campaign to prevent antimicrobial resistance. Pediatr Infect Dis J. 2009;28:1047–51.CrossRefPubMedPubMedCentral
33.
go back to reference Spyridis N, Syridou G, Goossens H, et al. Variation in paediatric hospital antibiotic guidelines in Europe. Arch Dis Child. 2016;2016:72–6.CrossRef Spyridis N, Syridou G, Goossens H, et al. Variation in paediatric hospital antibiotic guidelines in Europe. Arch Dis Child. 2016;2016:72–6.CrossRef
34.
go back to reference Ericson JE, Thaden J, Cross HR, et al. No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants. Pediatr Infect Dis J. 2015;34:371–5.CrossRefPubMedPubMedCentral Ericson JE, Thaden J, Cross HR, et al. No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants. Pediatr Infect Dis J. 2015;34:371–5.CrossRefPubMedPubMedCentral
35.
go back to reference Thaden JT, Ericson JE, Cross H, et al. Survival benefit of empirical therapy for Staphylococcus aureus bloodstream infections in infants. Pediatr Infect Dis J. 2015;34:1175–9.CrossRefPubMedPubMedCentral Thaden JT, Ericson JE, Cross H, et al. Survival benefit of empirical therapy for Staphylococcus aureus bloodstream infections in infants. Pediatr Infect Dis J. 2015;34:1175–9.CrossRefPubMedPubMedCentral
36.
go back to reference Popoola VO, Colantuoni E, Suwantarat N, et al. Active surveillance cultures and decolonization to reduce staphylococcus aureus infections in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2016;37:381–7.CrossRefPubMedPubMedCentral Popoola VO, Colantuoni E, Suwantarat N, et al. Active surveillance cultures and decolonization to reduce staphylococcus aureus infections in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2016;37:381–7.CrossRefPubMedPubMedCentral
37.
go back to reference Wisgrill L, Zizka J, Unterasinger L, et al. Active surveillance cultures and targeted decolonization are associated with reduced methicillin-susceptible Staphylococcus aureus infections in VLBW infants. Neonatology. 2017;112:267–73.CrossRefPubMed Wisgrill L, Zizka J, Unterasinger L, et al. Active surveillance cultures and targeted decolonization are associated with reduced methicillin-susceptible Staphylococcus aureus infections in VLBW infants. Neonatology. 2017;112:267–73.CrossRefPubMed
38.
go back to reference Holzmann-Pazgal G, Khan AM, Northrup TF, Domonoske C, Eichenwald EC. Decreasing vancomycin utilization in a neonatal intensive care unit. Am J Infect Control. 2015;43:1255–7.CrossRefPubMed Holzmann-Pazgal G, Khan AM, Northrup TF, Domonoske C, Eichenwald EC. Decreasing vancomycin utilization in a neonatal intensive care unit. Am J Infect Control. 2015;43:1255–7.CrossRefPubMed
39.
go back to reference Le J, Nguyen T, Okamoto M, McKamy S, Lieberman JM. Impact of empiric antibiotic use on development of infections caused by extended-spectrum beta-lactamase bacteria in a neonatal intensive care unit. Pediatr Infect Dis J. 2008;27:314–8.CrossRefPubMed Le J, Nguyen T, Okamoto M, McKamy S, Lieberman JM. Impact of empiric antibiotic use on development of infections caused by extended-spectrum beta-lactamase bacteria in a neonatal intensive care unit. Pediatr Infect Dis J. 2008;27:314–8.CrossRefPubMed
40.
go back to reference Stocker M, Ferrao E, Banya W, Cheong J, Macrae D, Furck A. Antibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resources. BMC Pediatr 2012;12196. Stocker M, Ferrao E, Banya W, Cheong J, Macrae D, Furck A. Antibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resources. BMC Pediatr 2012;12196.
41.
go back to reference Simon A, Tenenbaum T. Surveillance of multidrug-resistant Gram-negative pathogens in high-risk neonates-does it make a difference? Pediatr Infect Dis J. 2013;32:407–9.CrossRefPubMed Simon A, Tenenbaum T. Surveillance of multidrug-resistant Gram-negative pathogens in high-risk neonates-does it make a difference? Pediatr Infect Dis J. 2013;32:407–9.CrossRefPubMed
42.
go back to reference Seidel J, Haller S, Eckmanns T, Harder T. Routine screening for colonization by Gram-negative bacteria in neonates at intensive care units for the prediction of sepsis: systematic review and meta-analysis. J Hosp Infect. 2018 (in press). Seidel J, Haller S, Eckmanns T, Harder T. Routine screening for colonization by Gram-negative bacteria in neonates at intensive care units for the prediction of sepsis: systematic review and meta-analysis. J Hosp Infect. 2018 (in press).
43.
go back to reference Folgori L, Tersigni C, Hsia Y, et al. The relationship between Gram-negative colonization and bloodstream infections in neonates: a systematic review and meta-analysis. Clin Microbiol Infect. 2018;24:251–7.CrossRefPubMed Folgori L, Tersigni C, Hsia Y, et al. The relationship between Gram-negative colonization and bloodstream infections in neonates: a systematic review and meta-analysis. Clin Microbiol Infect. 2018;24:251–7.CrossRefPubMed
44.
go back to reference Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch Institut Berlin. Prävention von Gefäßkatheter-assoziierten Infektionen bei Früh- und Neugeborenen—Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robeert Koch Instituut. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61:608–26.CrossRef Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch Institut Berlin. Prävention von Gefäßkatheter-assoziierten Infektionen bei Früh- und Neugeborenen—Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robeert Koch Instituut. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61:608–26.CrossRef
46.
go back to reference Berger A, Rohrmeister K, Haiden N, Assadian O, Kretzer V, Kohlhauser C. Serratia marcescens in the neonatal intensive care unit: re-emphasis of the potentially devastating sequelae. Wien Klin Wochenschr. 2002;114:1017–22.PubMed Berger A, Rohrmeister K, Haiden N, Assadian O, Kretzer V, Kohlhauser C. Serratia marcescens in the neonatal intensive care unit: re-emphasis of the potentially devastating sequelae. Wien Klin Wochenschr. 2002;114:1017–22.PubMed
47.
48.
go back to reference Pauwels S, Allegaert K. Therapeutic drug monitoring in neonates. Arch Dis Child. 2016;101:377–81.CrossRefPubMed Pauwels S, Allegaert K. Therapeutic drug monitoring in neonates. Arch Dis Child. 2016;101:377–81.CrossRefPubMed
49.
go back to reference Fonzo-Christe C, Guignard B, Zaugg C, et al. Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newborns. Ther Drug Monit. 2014;36:656–62.CrossRefPubMed Fonzo-Christe C, Guignard B, Zaugg C, et al. Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newborns. Ther Drug Monit. 2014;36:656–62.CrossRefPubMed
50.
go back to reference Fuchs A, Guidi M, Giannoni E, et al. Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates. Br J Clin Pharmacol. 2014;78:1090–101.CrossRefPubMedPubMedCentral Fuchs A, Guidi M, Giannoni E, et al. Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates. Br J Clin Pharmacol. 2014;78:1090–101.CrossRefPubMedPubMedCentral
51.
go back to reference Antolik TL, Cunningham KJ, Alabsi S, Reimer RA. Empirical gentamicin dosing based on serum creatinine levels in premature and term neonates. Am J Health Syst Pharm. 2017;74:466–72.CrossRefPubMed Antolik TL, Cunningham KJ, Alabsi S, Reimer RA. Empirical gentamicin dosing based on serum creatinine levels in premature and term neonates. Am J Health Syst Pharm. 2017;74:466–72.CrossRefPubMed
52.
go back to reference Frymoyer A, Hersh AL, El-Komy MH, et al. Association between vancomycin trough concentration and area under the concentration-time curve in neonates. Antimicrob Agents Chemother. 2014;58:6454–61.CrossRefPubMedPubMedCentral Frymoyer A, Hersh AL, El-Komy MH, et al. Association between vancomycin trough concentration and area under the concentration-time curve in neonates. Antimicrob Agents Chemother. 2014;58:6454–61.CrossRefPubMedPubMedCentral
53.
go back to reference Cole TS, Riordan A. Vancomycin dosing in children: what is the question? Arch Dis Child. 2013;98:994–7.CrossRefPubMed Cole TS, Riordan A. Vancomycin dosing in children: what is the question? Arch Dis Child. 2013;98:994–7.CrossRefPubMed
54.
go back to reference Ringenberg T, Robinson C, Meyers R, et al. Achievement of therapeutic vancomycin trough serum concentrations with empiric dosing in neonatal intensive care unit patients. Pediatr Infect Dis J. 2015;34:742–7.CrossRefPubMed Ringenberg T, Robinson C, Meyers R, et al. Achievement of therapeutic vancomycin trough serum concentrations with empiric dosing in neonatal intensive care unit patients. Pediatr Infect Dis J. 2015;34:742–7.CrossRefPubMed
55.
go back to reference Lestner JM, Hill LF, Heath PT, Sharland M. Vancomycin toxicity in neonates: a review of the evidence. Curr Opin Infect Dis. 2016;29:237–47.CrossRefPubMed Lestner JM, Hill LF, Heath PT, Sharland M. Vancomycin toxicity in neonates: a review of the evidence. Curr Opin Infect Dis. 2016;29:237–47.CrossRefPubMed
Metadata
Title
Management of early- and late-onset sepsis: results from a survey in 80 German NICUs
Authors
Jana E. Litz
Sybelle Goedicke-Fritz
Christoph Härtel
Michael Zemlin
Arne Simon
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 4/2019
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-018-1263-9

Other articles of this Issue 4/2019

Infection 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine